María Ángeles López‐García

<i>FGFR1</i> Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

Nicholas C. Turner, Alex Pearson, Rachel Sharpe et al. · Cancer Research · 2010 · 712 citations · Full text

Endocrine Oncology, Breast Oncology, Endocrine-related Cancer +14

The molecular underpinning of lobular histological growth pattern: a genome‐wide transcriptomic analysis of invasive lobular carcinomas and grade‐ and molecular subtype‐matched invasive ductal carcinomas of no special type

Britta Weigelt, Felipe C. Geyer, Rachael Natrajan et al. · The Journal of Pathology · 2009 · 234 citations · Full text

Micro‐RNA signature of the epithelial–mesenchymal transition in endometrial carcinosarcoma

María Ángeles Castilla, Gema Moreno‐Bueno, Laura Romero‐Pérez et al. · The Journal of Pathology · 2010 · 226 citations

Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer

Konstantin J. Dedes, Rachael Natrajan, Maryou Lambros et al. · European Journal of Cancer · 2010 · 149 citations

Specific Subgroups, Systems Biology, Breast Oncology +6

MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes

María Ángeles Castilla, Juan Díaz‐Martín, David Sarrió et al. · PLoS ONE · 2012 · 100 citations · Full text

Breast Oncology, Spontaneous Emt, Pathology +16